Cargando…
Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin
BACKGROUND: β-Glucosidase (β-Glu) can activate amygdalin to kill prostate cancer cells, but the poor specificity of this killing effect may cause severe general toxicity in vivo, limiting the practical clinical application of this approach. MATERIALS AND METHODS: In this study, starch-coated magneti...
Autores principales: | Zhou, Jie, Hou, Jing, Rao, Jun, Zhou, Conghui, Liu, Yunlong, Gao, Wenxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334483/ https://www.ncbi.nlm.nih.gov/pubmed/32636623 http://dx.doi.org/10.2147/IJN.S242359 |
Ejemplares similares
-
Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles
por: Zhou, Jie, et al.
Publicado: (2014) -
Development of Inhibitor-Directed Enzyme Prodrug Therapy
(IDEPT) for Prostate Cancer
por: Martin, Stacy E., et al.
Publicado: (2014) -
In Vivo Growth Inhibition of Human Caucasian Prostate Adenocarcinoma in Nude Mice Induced by Amygdalin with Metabolic Enzyme Combinations
por: Alwan, Ahmed Mohammed, et al.
Publicado: (2022) -
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003) -
Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells
por: Tsaur, Igor, et al.
Publicado: (2022)